Malaria | Malaria

We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Continue

Wellcome Trust websites

Home

Malaria at a glance


The global problem	The mosquito
The parasite	Malaria and people
The parasite genome	Malaria, treatment and control

News

Features and backgrounds

Wellcome Trust and malaria

The Wellcome Trust is one of the world's leading supporters of research in tropical medicine. Over the last ten years it has funded £150 million of research on malaria, and has supported a number of initiatives that aim to tackle the huge burden of malaria in the developing world.

Major Overseas Programmes

Kenya: the KEMRI-Wellcome Trust Research Programme based at Kilifi on the Kenyan coast and in Nairobi.
Malawi: the Malawi-Liverpool-Wellcome Trust Research Programme, based in Blantyre.
South-east Asia: the Wellcome Trust South-east Asia Programme, based in Thailand and Vietnam.

Wellcome Trust Sanger Institute

One of the world's leading centres of genome sequencing and analysis, the Sanger Institute played a key role in the sequencing of the malaria parasite genome.

'Fingerprinting' malaria parasite drug resistance offers new tool for tracking public health threat: Resistance to the frontline antimalarial drug - artemisinin - can be identified and tracked by analysing the genetic fingerprint of parasite populations. 29/04/2013

Study describes declining efficacy of malaria vaccine candidate: Long-term follow-up of a phase II study from researchers in Kenya shows that the efficacy of a malaria vaccine candidate, RTS,S, wanes over time and varies with exposure to the malaria parasite. 21/03/2013

Common enzyme deficiency may hinder plans to eradicate malaria: A new study estimates that around 350 million people in malaria-endemic countries are deficient in an enzyme that means they can suffer severe complications from taking primaquine to treat relapsing malaria. 15/11/2012

Candidate vaccine reduces malaria by approximately one-third in African infants: Results from a large-scale clinical trial have shown that a new candidate vaccine being developed by GlaxoSmithKline can help protect African infants against malaria. 12/11/2012

Mobile phone data maps malaria spread: New research has revealed how human travel patterns contribute to the spread of malaria. 12/10/2012

75th stories: Nick White, malaria and artemisinin: In one of 14 features to mark the 75th anniversary of the Wellcome Trust, Anjana Ahuja looks at Nick White, Director of the Wellcome Trust's South-east Asia Major Overseas Programme.

Video feature: Kevin Marsh and and the challenges of fighting tropical disease in Africa: In this video Kevin Marsh introduces his work and discusses his most exciting current projects.

Two decades of research in Vietnam: The Wellcome Trust Vietnam Major Overseas Programme is a flourishing clinical research unit embedded in the Hospital of Tropical Diseases in Ho Chi Minh City.

Mapping malaria: Integrated maps, combining data from satellites and other sources are providing new insights into malaria interventions. Mun-Keat Looi talks to Abdisalan Noor, a Wellcome Trust Research Training Fellow in Kenya, on his work in the field of geospatial modelling.